🔎 Trials Near Me

Home › Graft-Versus-Host Disease

Graft-Versus-Host Disease clinical trials recruiting in the U.S.

34 studies for Graft-Versus-Host Disease are recruiting participants at sites across the United States.

Cities with the most studies

By state

Recently updated studies

Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives

RecruitingObservational studyHealthy volunteers welcome
Ages 18 to 60 · All sexes · Updated Oct 2, 2026 · NCT00001529

Vulvovaginal Graft-versus-Host Disease: Diagnosis and Microbiome Evaluation

RecruitingObservational study
Ages 18 to 70 · Women · Updated Sep 29, 2026 · NCT06649201

Multidisciplinary Intervention for Adults With Chronic Graft-versus-host Disease

Recruiting
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT06910969

Evaluation of Patients With Immune Function Abnormalities

RecruitingObservational studyHealthy volunteers welcome
All ages · All sexes · Updated Sep 22, 2026 · NCT00128973

Long-term Evaluation and Follow-up Care of Patients Treated With Stem Cell Transplants

RecruitingObservational studyHealthy volunteers welcome
Ages 7 to 80 · All sexes · Updated Sep 1, 2026 · NCT00106925

Vitamin A Supplementation in Allogeneic Stem Cell Transplantation.

RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 24, 2026 · NCT06450925

Dose-Escalation Trial of Mesenchymal Stromal Cells in Patients With Medical Xerostomia

RecruitingPhase 1
Ages 18 to 90 · All sexes · Updated Aug 19, 2026 · NCT06392711

Ex Vivo-Expanded Regulatory T Cells Plus Low-Dose Interleukin-2 for Steroid-Refractory Chronic GVHD

RecruitingPhase 1
Ages 2 and older · All sexes · Updated Jul 23, 2026 · NCT06991361

A Study of Belumosudil in People at Risk of Developing Graft-Versus-Host Disease After a Stem Cell Transplant

RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jun 29, 2026 · NCT07006506

A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)

RecruitingPhase 2
Ages 2 and older · All sexes · Updated Jun 16, 2026 · NCT04710576

Post-Transplant Cyclophosphamide, Bortezomib and Abatacept for the Prevention of Graft-versus-Host-Disease (GvHD)

RecruitingPhase 1/2
Ages 14 to 100 · All sexes · Updated May 29, 2026 · NCT05289167

A Study of Photobiomodulation (PBM) Therapy in People With Oral Graft-Versus-Host Disease (GVHD) After Stem Cell Transplant

RecruitingPhase 2
Ages 4 and older · All sexes · Updated May 22, 2026 · NCT05675930

Cord Blood Transplantation in Children and Young Adults With Blood Cancer

RecruitingPhase 2
Up to age 26 · All sexes · Updated May 14, 2026 · NCT07566377

Extended vs Short-term Abatacept Dosing for Graft Versus Host Disease Prophylaxis

RecruitingPhase 2
Ages 2 and older · All sexes · Updated May 11, 2026 · NCT04380740

Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma

RecruitingPhase 2
Ages 18 and older · All sexes · Updated Apr 15, 2026 · NCT07356245

Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders

RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Apr 15, 2026 · NCT06434363

A Feasibility Study Using CLINIMACS® for Alpha/Beta T-Cell Depletion in Stem Cell Transplant

Recruiting
Up to age 30 · All sexes · Updated Apr 13, 2026 · NCT04337515

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.